(HUN) Huntsman - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4470111075
HUN: Chemicals, Plastics, Resins, Adhesives, Coatings, Polymers, Materials
Huntsman Corporation is a global leader in the production of specialized chemicals, operating across three distinct business segments: Polyurethanes, Performance Products, and Advanced Materials. This diversification allows the company to cater to a wide array of industries, ensuring stability and growth potential.
The Polyurethanes segment is a cornerstone of Huntsmans business, manufacturing essential chemicals like methyl diphenyl diisocyanate and polyols, which are critical in the production of foams, coatings, and adhesives. Additionally, this segment produces aniline and benzene derivatives, which are vital in various industrial applications.
The Performance Products segment focuses on amines and maleic anhydrides, serving industries such as water treatment, epoxy resins, and pharmaceuticals. This segment underscores Huntsmans commitment to innovation and meeting the evolving needs of its customers.
The Advanced Materials segment specializes in high-performance polymers and epoxy formulations, crucial for aerospace, electronics, and renewable energy. This segment highlights Huntsmans role in advancing technologies that are pivotal to future industries.
Huntsmans products are integral to numerous applications, including automotive parts, construction materials, and consumer goods. This broad market reach underscores the companys strategic importance across various sectors.
With a robust distribution network spanning the globe, Huntsman ensures efficient delivery and dedicated customer support, enhancing its competitive edge in the market.
Financially, Huntsman boasts a market capitalization of approximately $2.9 billion, with a forward P/E ratio of 30.86, indicating investor confidence in its future prospects. The companys debt-to-equity ratio and return on equity further illustrate its financial health and management efficiency.
Additional Sources for HUN Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
HUN Stock Overview
Market Cap in USD | 2,333m |
Sector | Basic Materials |
Industry | Chemicals |
GiC Sub-Industry | Diversified Chemicals |
IPO / Inception | 2005-02-11 |
HUN Stock Ratings
Growth Rating | -20.6 |
Fundamental | -17.6 |
Dividend Rating | 82.9 |
Rel. Strength | -37.5 |
Analysts | 3.4/5 |
Fair Price Momentum | 11.94 USD |
Fair Price DCF | 10.75 USD |
HUN Dividends
Dividend Yield 12m | 5.97% |
Yield on Cost 5y | 7.75% |
Annual Growth 5y | 9.00% |
Payout Consistency | 97.1% |
HUN Growth Ratios
Growth Correlation 3m | -66.6% |
Growth Correlation 12m | -87.7% |
Growth Correlation 5y | -10.7% |
CAGR 5y | 0.21% |
CAGR/Max DD 5y | 0.00 |
Sharpe Ratio 12m | -1.27 |
Alpha | -48.45 |
Beta | 0.806 |
Volatility | 50.82% |
Current Volume | 0k |
Average Volume 20d | 3595.2k |
As of April 19, 2025, the stock is trading at USD 13.04 with a total of 0 shares traded.
Over the past week, the price has changed by -4.47%, over one month by -25.23%, over three months by -26.14% and over the past year by -42.21%.
Neither. Based on ValueRay Fundamental Analyses, Huntsman is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -17.60 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HUN as of April 2025 is 11.94. This means that HUN is currently overvalued and has a potential downside of -8.44%.
Huntsman has received a consensus analysts rating of 3.40. Therefor, it is recommend to hold HUN.
- Strong Buy: 3
- Buy: 1
- Hold: 10
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, HUN Huntsman will be worth about 13.2 in April 2026. The stock is currently trading at 13.04. This means that the stock has a potential upside of +0.92%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 19.6 | 50.5% |
Analysts Target Price | 22.5 | 72.9% |
ValueRay Target Price | 13.2 | 0.9% |